ZHONGXING LIAO to Benchmarking
This is a "connection" page, showing publications ZHONGXING LIAO has written about Benchmarking.
Connection Strength
0.046
-
Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non-Small-Cell Lung Cancer Reveals EGFR Mutations to Be Associated With Longer Overall Survival. JCO Precis Oncol. 2023 01; 7:e2200540.
Score: 0.046